Coloplast with growth in revenue, but sales in China are challenging
Coloplast is downgrading its expectations for the financial year, despite growth in the ostomy business. The Danish company states that they expect a reported revenue growth of 9-10 percent against …
Coloplast with growth in revenue, but sales in China are challenging Read More